Kinled is a prominent brand that retains the assets of the Anglo-Austrian Aisher Family through direct investments in the Life Science and Digital Technology sectors. With a strong focus on innovation, Kinled invests in various industries to foster academic projects and develop successful commercial businesses. In the life sciences field, Kinled concentrates on biomedical technology, medical devices, bio pharmaceuticals, and healthcare services, which make up more than half of its portfolio.

In the digital technologies sector, the company invests in SaaS-enabled networks and marketplaces, aiming to democratize markets and offer consumers a broader array of services. Additionally, Kinled is actively involved in fintech, supporting companies that challenge traditional institutions by providing superior service through embedded payment platforms, insurance, real estate, lending, and banking. As a partner in multiple life science investment companies and digital technology funds, Kinled manages significant assets and has a strong global presence